Effective down-regulation of Breast Cancer Resistance Protein (BCRP) by siRNA delivery using lipid-substituted aliphatic polymers

被引:35
作者
Aliabadi, Hamidreza Montazeri
Landry, Breanne
Mandipoor, Parvin
Hsu, Charlie Y. M. [3 ]
Uludag, Hasan [1 ,2 ,3 ]
机构
[1] Univ Alberta, Fac Engn, Dept Chem & Mat Engn, Edmonton, AB T6G 2E1, Canada
[2] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada
[3] Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada
关键词
siRNA; Breast Cancer Resistance Protein (BCRP); Polyethyleneimine; Lipid-substitution; Multidrug resistance; siRNA delivery; DOUBLE-STRANDED-RNA; WATER-SOLUBLE LIPOPOLYMER; SMALL INTERFERING RNAS; MULTIDRUG-RESISTANCE; GENE DELIVERY; IN-VIVO; DRUG-RESISTANCE; P-GLYCOPROTEIN; CELLS; TRANSPORTER;
D O I
10.1016/j.ejpb.2012.01.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Breast Cancer Resistance Protein (BCRP, ABCG2) is an efflux protein whose aberrant activity has been linked to multidrug resistance in cancer. Although siRNA delivery to down-regulate BCRP expression is promising to sensitize tumor cells against drugs, therapeutic use of siRNA requires effective carriers that can deliver siRNA intracellularly with minimal toxicity on target cells. This study explored the feasibility of special class of cationic polymers, namely lipid-substituted low molecular weight (2 kDa) polyethyleneimine (PEI), as a carrier for siRNA-mediated BCRP down-regulation. Structure-function studies methodically evaluated the effect of a range of lipophilic substitutions for siRNA delivery and BCRP down-regulation. Our results showed a significant increase in siRNA delivery as a function of lipid substitution for a range of lipids ranging from C8 to C18. The BCRP silencing was correlated to siRNA delivery efficiency of the polymers, and effectively lasted for similar to 5 days after a single treatment of siRNA. BCRP down-regulation sensitized the drug-resistant cells to cytotoxic effect of mitoxantrone by a similar to 14-fold decrease in the IC50 value, whose effect was evident even after 14 days. This study demonstrated the possibility of functional siRNA delivery by lipid-modified low molecular weight PEI and highlighted the importance of the extent and nature of lipid substitution in effective siRNA delivery. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:33 / 42
页数:10
相关论文
共 56 条
[1]   Cationic Polymer-Mediated Small Interfering RNA Delivery for P-glycoprotein Down-Regulation in Tumor Cells [J].
Abbasi, Meysam ;
Lavasanifar, Afsaneh ;
Berthiaume, Luc G. ;
Weinfeld, Michael ;
Uludag, Hasan .
CANCER, 2010, 116 (23) :5544-5554
[2]   Impact of Lipid Substitution on Assembly and Delivery of siRNA by Cationic Polymers [J].
Aliabadi, Hamidreza Montazeri ;
Landry, Breanne ;
Bahadur, Remant K. ;
Neamnark, Artphop ;
Suwantong, Orawan ;
Uludag, Hasan .
MACROMOLECULAR BIOSCIENCE, 2011, 11 (05) :662-672
[3]  
Allen JD, 2002, MOL CANCER THER, V1, P427
[4]   ABCG2: the key to chemoresistance in cancer stem cells? [J].
An, Yi ;
Ongkeko, Weg M. .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2009, 5 (12) :1529-1542
[5]   Linear polyethylenimine as a tool for comparative studies of antisense and short double-stranded RNA oligonucleotides [J].
Bologna, JC ;
Dorn, G ;
Natt, F ;
Weiler, J .
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2003, 22 (5-8) :1729-1731
[6]   A VERSATILE VECTOR FOR GENE AND OLIGONUCLEOTIDE TRANSFER INTO CELLS IN CULTURE AND IN-VIVO - POLYETHYLENIMINE [J].
BOUSSIF, O ;
LEZOUALCH, F ;
ZANTA, MA ;
MERGNY, MD ;
SCHERMAN, D ;
DEMENEIX, B ;
BEHR, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) :7297-7301
[7]   Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer [J].
Coley, Helen M. .
CANCER TREATMENT REVIEWS, 2008, 34 (04) :378-390
[8]   Tumour stem cells and drug resistance [J].
Dean, M ;
Fojo, T ;
Bates, S .
NATURE REVIEWS CANCER, 2005, 5 (04) :275-284
[9]   The human ATP-binding cassette (ABC) transporter superfamily [J].
Dean, M ;
Rzhetsky, A ;
Allikmets, R .
GENOME RESEARCH, 2001, 11 (07) :1156-1166
[10]   Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2) [J].
Doyle, LA ;
Ross, DD .
ONCOGENE, 2003, 22 (47) :7340-7358